IBT
CELG

International Biotechnology Trust’s Celgene Corp CELG Stock Holding History

International Biotechnology Trust’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-171,022
Closed -$17M – 67
2019
Q3 		$17M Buy
171,022
+28,500
+20% +$2.71M 7.85% 2
2019
Q2 		$13.2M Sell
142,522
-93,000
-39% -$8.83M 4.88% 4
2019
Q1 		$22.2M Buy
235,522
+10,000
+4% +$875K 8.21% 1
2018
Q4 		$11.4M Sell
225,522
-28,000
-11% -$2.07M 7.05% 3
2018
Q3 		$17.4M Buy
253,522
+64,000
+34% +$5.66M 8.27% 1
2018
Q2 		$15.1M Sell
189,522
-16,000
-8% -$1.33M 5.78% 2
2018
Q1 		$18.3M Buy
205,522
+15,500
+8% +$1.49M 7.15% 1
2017
Q4 		$19.8M Buy
190,022
+9,500
+5% +$1.07M 6.99% 2
2017
Q3 		$26.3M Buy
180,522
+3,000
+2% +$409K 10.24% 1
2017
Q2 		$23.1M Buy
177,522
+3,500
+2% +$429K 8.76% 2
2017
Q1 		$21.7M Sell
174,022
-7,700
-4% -$921K 8.29% 1
2016
Q4 		$21M Buy
+181,722
New +$20.2M 9.48% 1

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

International Biotechnology Trust's CELG Position: Q4 2019 in Review

International Biotechnology Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 171,022 shares — an estimated $17M sold.

International Biotechnology Trust first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $26.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • International Biotechnology Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • International Biotechnology Trust sold 171,022 Celgene Corp shares in Q4 2019, an estimated $17M.
  • International Biotechnology Trust first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • International Biotechnology Trust's Celgene Corp position peaked at $26.3M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on International Biotechnology Trust's 13F filing for Q4 2019, filed 18 May 2020.